Dishman Carbogen Amcis Limited (NSE:DCAL)

India · Delayed Price · Currency is INR

164.51

+6.26 (3.96%)

Mar 10, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Medical Labs & Research	27.12B	26.16B	24.13B	21.41B	-
Medical Labs & Research Growth	3.66%	8.41%	12.72%	-	-
Contract Research and Manufacturing Services (CRAMS)	-	-	-	-	14.32B
Contract Research and Manufacturing Services (CRAMS) Growth	-	-	-	-	-5.14%
Vitamin-D, Bulk Drugs, Quats, Speciality Chemicals and Traded Goods	-	-	-	-	4.80B
Vitamin-D, Bulk Drugs, Quats, Speciality Chemicals and Traded Goods Growth	-	-	-	-	-10.11%
Total	27.12B	26.16B	24.13B	21.41B	19.12B
Total Growth	3.66%	8.41%	12.72%	11.96%	-6.44%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	439.40M
India Growth	-56.30%
Rest of The World	18.68B
Rest of The World Growth	-3.86%
Total	19.12B
Total Growth	-6.44%

Source: S&P Global Market Intelligence.